Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
Schneider, Constanze, Oellerich, Thomas, Baldauf, Hanna-Mari, Schwarz, Sarah-Marie, Thomas, Dominique, Flick, Robert, Bohnenberger, Hanibal, Kaderali, Lars, Stegmann, Lena, Cremer, Anjali, Martin, MarVolume:
23
Language:
english
Journal:
Nature Medicine
DOI:
10.1038/nm0617-788a
Date:
June, 2017
File:
PDF, 58 KB
english, 2017